FDA.reportPublic FDA data

1 ML Beyfortus 100 MG/ML Prefilled Syringe

RxCUI
2642415
RxNorm name
1 ML Beyfortus 100 MG/ML Prefilled Syringe
Display name
1 ML Beyfortus 100 MG/ML Prefilled Syringe
Full name
1 ML Beyfortus 100 MG/ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761328Beyfortusnirsevimab-alip351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BEYFORTUSNIRSEVIMABSanofi Vaccines US Inc.2f08fa60-f674-432d-801b-1f9514bd9b392026-06-26Warnings, Adverse reactionsExact identifier
rxcui: 2642415

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2f08fa60-f674-432d-801b-1f9514bd9b391 ML Beyfortus 100 MG/ML Prefilled SyringeSY26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428
2f08fa60-f674-432d-801b-1f9514bd9b391 ML nirsevimab-alip 100 MG/ML Prefilled Syringe [Beyfortus]SBD26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428
2f08fa60-f674-432d-801b-1f9514bd9b39Beyfortus 100 MG per 1 ML Prefilled SyringeSY26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428
2f08fa60-f674-432d-801b-1f9514bd9b39Beyfortus 100 MG in 1 ML Prefilled SyringePSN26These highlights do not include all the information needed to use BEYFORTUS ® safely and effectively. See full prescribing information for BEYFORTUS. BEYFORTUS (nirsevimab-alip) injection, for intramuscular use Initial U.S. Approval: 202320260428